Skip to main content
Erschienen in: World Journal of Surgery 8/2018

29.01.2018 | Original Scientific Report

Incidence and Predictors of Unsuspected Recurrent Laryngeal Nerve Lymph Node Metastases After Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma

verfasst von: Zhi-Gang Li, Xiao-Bin Zhang, Yu-Wen Wen, Yun-Hen Liu, Yin-Kai Chao

Erschienen in: World Journal of Surgery | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Radical lymph node (LN) dissection along the recurrent laryngeal nerve (RLN) area carries a substantial morbidity rate, and its usefulness in neoadjuvant chemoradiotherapy (nCRT)-treated esophageal cancer patients remains unclear.

Methods

This study was conducted in two Asian thoracic surgery centers. Patients with esophageal squamous cell carcinoma (ESCC) who were judged to be ycN-RLN(−) after nCRT and received bilateral RLN LN dissection were eligible. The incidence of unsuspected RLN LN involvement was analyzed, and we used least absolute shrinkage and selection operator (LASSO) regression to identify its predictors.

Results

A total of 56 patients (53 males and 3 females; mean age: 55 years) were included. The upper mediastinum—including the bilateral RLN area—was covered by the radiation field in 48 (85.3%) patients. Although all of them were judged as ycN-RLN(−), unsuspected RLN LN involvement was identified on pathological examination in 11 (19.6%) subjects, being the only positive nodal station in seven. LASSO regression identified the pre-nCRT RLN LN(cN-RLN) status as the only independent predictor of ypN-RLN positivity; in contrast, neither the tumor location nor the radiation dose to the upper mediastinum were independently associated with ypN-RLN(+). RLN nodal dissection resulted in positive LN discovery rates of 30.8 and 10% in ycN-RLN(−) patients who had positive and negative cN-RLNs before nCRT, respectively. Consequently, 23.1 and 6.7% of patients in each subgroup would have been understaged in the absence of RLN nodal dissection.

Conclusion

Nearly one-fifth of ESCC patients who were judged to be ycN-RLN(−) unexpectedly had positive ypN-RLN. The pre-nCRT cN-RLN status plays a key role in the selection of patients that should undergo RLN LN dissection after nCRT.
Literatur
1.
Zurück zum Zitat Li B, Chen H, Xiang J et al (2012) Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: a single-institution experience. J Thorac Cardiovasc Surg 144:778–786CrossRefPubMed Li B, Chen H, Xiang J et al (2012) Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: a single-institution experience. J Thorac Cardiovasc Surg 144:778–786CrossRefPubMed
2.
Zurück zum Zitat Udagawa H, Ueno M, Shinohara H et al (2012) The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol 106:742–747CrossRefPubMed Udagawa H, Ueno M, Shinohara H et al (2012) The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol 106:742–747CrossRefPubMed
3.
Zurück zum Zitat Tachimori Y, Ozawa S, Numasaki H et al (2016) Efficacy of lymph node dissection for each station based on esophageal tumor location. Esophagus 13:138–145CrossRef Tachimori Y, Ozawa S, Numasaki H et al (2016) Efficacy of lymph node dissection for each station based on esophageal tumor location. Esophagus 13:138–145CrossRef
4.
Zurück zum Zitat Tan Z, Ma G, Zhao J et al (2014) Impact of thoracic recurrent laryngeal node dissection: 508 patients with tri-incisional esophagectomy. J Gastrointest Surg 18:187–193CrossRefPubMed Tan Z, Ma G, Zhao J et al (2014) Impact of thoracic recurrent laryngeal node dissection: 508 patients with tri-incisional esophagectomy. J Gastrointest Surg 18:187–193CrossRefPubMed
7.
Zurück zum Zitat Pertl L, Zacherl J, Mancusi G et al (2011) High risk of unilateral recurrent laryngeal nerve paralysis after esophagectomy using cervical anastomosis. Eur Arch Otorhinolaryngol 268:1605–1610CrossRefPubMed Pertl L, Zacherl J, Mancusi G et al (2011) High risk of unilateral recurrent laryngeal nerve paralysis after esophagectomy using cervical anastomosis. Eur Arch Otorhinolaryngol 268:1605–1610CrossRefPubMed
8.
Zurück zum Zitat Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12:681–692CrossRefPubMed Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12:681–692CrossRefPubMed
9.
Zurück zum Zitat Shapiro J, van Lanschot JJB, Hulshof MC et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098CrossRefPubMed Shapiro J, van Lanschot JJB, Hulshof MC et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098CrossRefPubMed
10.
Zurück zum Zitat van Hagen P, Hulshof M, Van Lanschot J et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084CrossRefPubMed van Hagen P, Hulshof M, Van Lanschot J et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084CrossRefPubMed
11.
Zurück zum Zitat Talsma AK, Shapiro J, Looman CW et al (2014) Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg 260:786–793CrossRef Talsma AK, Shapiro J, Looman CW et al (2014) Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg 260:786–793CrossRef
12.
Zurück zum Zitat Shridhar R, Hoffe SE, Almhanna K et al (2013) Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Surg Oncol 20:3038–3043CrossRefPubMed Shridhar R, Hoffe SE, Almhanna K et al (2013) Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Surg Oncol 20:3038–3043CrossRefPubMed
13.
Zurück zum Zitat Rice TW, Ishwaran H, Ferguson MK et al (2017) Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncology 12:36–42CrossRef Rice TW, Ishwaran H, Ferguson MK et al (2017) Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncology 12:36–42CrossRef
14.
Zurück zum Zitat Wong B (1994) More or less surgery for esophageal cancer: extent of lymphadenectomy in esophagectomy for squamous cell esophageal carcinoma How much is necessary. Dis Esoph 7:151–155CrossRef Wong B (1994) More or less surgery for esophageal cancer: extent of lymphadenectomy in esophagectomy for squamous cell esophageal carcinoma How much is necessary. Dis Esoph 7:151–155CrossRef
15.
Zurück zum Zitat Low DE, Alderson D, Cecconello I et al (2015) International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg 262:286–294CrossRefPubMed Low DE, Alderson D, Cecconello I et al (2015) International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg 262:286–294CrossRefPubMed
16.
Zurück zum Zitat Van Der Sluis PC, Verhage RJ, Van Der Horst S et al (2014) A new clinical scoring system to define pneumonia following esophagectomy for cancer. Digestive surgery 31:108–116CrossRefPubMed Van Der Sluis PC, Verhage RJ, Van Der Horst S et al (2014) A new clinical scoring system to define pneumonia following esophagectomy for cancer. Digestive surgery 31:108–116CrossRefPubMed
17.
Zurück zum Zitat Hsu H-Y, Chao Y-K, Hsieh C-H et al (2016) Postoperative adjuvant therapy improves survival in pathologic nonresponders after neoadjuvant chemoradiation for esophageal squamous cell carcinoma: a propensity-matched analysis. Ann Thorac Surg 102:1687–1693CrossRefPubMed Hsu H-Y, Chao Y-K, Hsieh C-H et al (2016) Postoperative adjuvant therapy improves survival in pathologic nonresponders after neoadjuvant chemoradiation for esophageal squamous cell carcinoma: a propensity-matched analysis. Ann Thorac Surg 102:1687–1693CrossRefPubMed
18.
Zurück zum Zitat Fyles AW, Milosevic M, Wong R et al (1998) Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48:149–156CrossRefPubMed Fyles AW, Milosevic M, Wong R et al (1998) Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48:149–156CrossRefPubMed
Metadaten
Titel
Incidence and Predictors of Unsuspected Recurrent Laryngeal Nerve Lymph Node Metastases After Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
verfasst von
Zhi-Gang Li
Xiao-Bin Zhang
Yu-Wen Wen
Yun-Hen Liu
Yin-Kai Chao
Publikationsdatum
29.01.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 8/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4516-y

Weitere Artikel der Ausgabe 8/2018

World Journal of Surgery 8/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.